by: Dr. Mercola
July 23, 2012
It was big news when court documents were unsealed revealing a whistleblower lawsuit accusing drug giant Merck of fraud and lying about the true efficacy of its mumps vaccine. Just about every media, large and small, picked it up and the world was abuzz about the hundreds of millions of dollars the lawsuit claimed Merck had defrauded from the U.S. government.
The Wall Street Journal published the story in the form of a Dow Jones news release written by Jon Kamp on June 22, 2012, and links to the story began popping up on social media like Facebook.
Then, suddenly, the link to the story no longer worked, and if anyone clicked on the link in social media, it would show up “page not found.” Apparently the story had been pulled, and when search engines and Internet archives wouldn’t even show it, it looked as if it had never been published on the Journal’s site at all. It was erased nearly clean–except for a small stock-watcher’s website, 4Traders.com, which did a good job of erasing it from its main site but didn’t catch it in the cache.
The question is, why did the WSJ pull the story and try to erase as if it never existed when there were actual court documents for evidence?
Is it possible that an event that occurred on June 251—three days after the story broke—could have influenced the story being pulled? On that day, the Wall Street Journal’s “elite” network of CFOs from the world’s top corporations met at the WSJ2. Merck is on that executive council3.
My team attempted to connect with the WSJ on this issue, but as of this time, we have not yet received an answer as to why this article was pulled.
Merck Accused of Falsifying Efficacy Studies and Lying about Effectiveness of Mumps Vaccine
Merck has actually been slapped with two class-action lawsuits over their mumps vaccine (which is part of the trivalent measles, mumps and rubella (MMR) vaccine). The first, which was initially filed in 2010, was unsealed late last month.
Two former Merck virologists, Stephen Krahling and Joan Wlochowski, claim they witnessed first-hand the improper testing and falsification of data that was done to hide the fact that the vaccine has significantly declined in effectiveness4.
By artificially inflating the efficacy, Merck was able to maintain its monopoly over the mumps vaccine market—and that is the main point of contention of the second class-action lawsuit, filed by Chatom Primary Care5.
According to Courthouse News Service6:
“Merck has known for a decade that its mumps vaccine is “far less effective” than it tells the government, and it falsified test results and sold millions of doses of “questionable efficacy,” flooding and monopolizing the market… Chatom says in its antitrust complaint that Merck falsely claims its mumps vaccine is 95 percent effective. That claim “deterred and excluded competing manufacturers,” who would enter the risky and expensive vaccine market only if they believed they could craft a better product…
Merck is the only manufacturer licensed by the FDA to sell the mumps vaccine in United States, and if it could not show that the vaccine was 95 percent effective, it risked losing its lucrative monopoly…
That’s why Merck found it critically important to keep claiming such a high efficacy rate, the complaint states. And, Chatom claims, that’s why Merck went to great lengths, including “manipulating its test procedures and falsifying the test results,” to prop up the bogus figure, though it knew that the attenuated virus from which it created the vaccine had been altered over the years during the manufacturing process, and that the quality of the vaccine had degraded as a result.”
How Merck Faked and Manipulated Vaccine Trials to Achieve Desired Results
According to these two lawsuits, Merck began a sham testing program in the late 1990’s to hide the declining efficacy of the vaccine. The objective of the fraudulent trials was to “report efficacy of 95 percent or higher regardless of the vaccine’s true efficacy.”
According to Krahling and Wlochowski’s complaint, they were threatened with jail were they to alert the FDA to the fraud being committed. The sham testing program was initially referred to as “Protocol 007,” the Chatom anti-trust claim states. Suzanne Humphries recently wrote an excellent summary for GreenMedInfo.com7, explaining in layman’s terms how the tests were manipulated8.
Here’s a brief extract. For more, please refer to the original source article:
“For the new testing method, the children’s blood was tested for its ability to neutralize the virus using the vaccine strain virus, instead of the wild type strain that is much more infective, and the one that your children would most likely catch… But still it was not 95% effective. In order to make the blood pass the test, antibodies from rabbits was added. The addition of rabbit antibody increased the efficacy to 100%. But that was not the end, because the test has to be done on pre-vaccine blood and post-vaccine blood.
Just the addition of rabbit antibody made the pre-vaccine blood go from 10% positive to 80% positive and that was such an obvious sign of foul play that yet another manipulation had to be made.
The desired end result is to have very low pre-vaccine antibody and 95% or more post-vaccine efficacy as measured by antibody neutralization. So, yet one more change in procedure was made: The pre-vaccine tests were all redone… According to the Merck scientists, they did this by fabricating the “plaque” counts on the pre-vaccine blood samples, counting plaques that were not there. What this allowed was a mathematical dilution of the pre-vaccine positive blood counts.”
This is a perfect example of how medical research can be manipulated to achieve desired results, and why it may be wise to question vaccine makers’ study results. Clearly, there needs to be a truly independent review in the mix… As reported by the Courthouse News Service9:
“Chatom claims that the falsification of test results occurred” with the knowledge, authority and approval of Merck’s senior management.”
While I do not advocate indiscriminately abstaining from all vaccines, I strongly encourage you to exercise a major dose of due diligence as vaccines can cause serious reactions that can have devastating consequences. I believe in informed consent and the freedom to choose. There can be little doubt anymore that drug companies are in it for the profits, and virtually no price seems too high for them when it comes to protecting their profit-making.